Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

ARCT.US Logo

ARCT.US - Current Price

$7.53

Company Information

▼
Company Name
Arcturus Therapeutics Holdings Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US03969T1097
CIK: 0001768224
CUSIP: 03969T109
Currency: USD
Full Time Employees: 174
Phone: 858 900 2660
Website: https://arcturusrx.com
Fiscal Year End: December
IPO Date: Apr 16, 2020
Description:

Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Address:

10285 Science Center Drive, San Diego, CA, United States, 92121

Directors & Officers

▼
Name Title Year Born
Mr. Joseph E. Payne M.Sc. Founder, President, CEO & Director 1972
Dr. Padmanabh Chivukula Ph.D. Founder, Chief Scientific Officer, COO & Secretary 1979
Mr. Lance Kurata Chief Legal Officer NA
Mr. Joseph Roberts Interim Principal Financial & Accounting Officer and Controller 1982
Ms. Neda Safarzadeh Vice President and Head of IR/PR & Marketing NA
Ms. Natasha O. Bowman Chief Human Resources Officer NA
Mr. Kevin T. Skol Chief Business Officer NA
Dr. Juergen Froehlich FCPh, M.D., MBA Chief Medical Officer 1956
Dr. Igor Smolenov M.D., Ph.D. Chief Development Officer NA
Dr. Ye Zhang Chief Regulatory Officer NA

Shares Statistics

▼
Shares Outstanding: 28.41M
Shares Float: 26.27M
% Insiders: 576.70%
% Institutions: 6,593.10%
Short % Float: 40.94%

Valuation Metrics

▼
Enterprise Value: $38.28M
Trailing P/E: 0.00
Forward P/E: 2.48

Financial Highlights

▼
Market Cap: $213.96M
EBITDA: $-75.19M
Book Value: $8.25
Earnings/Share: $-2.46
Profit Margin: -68.35%
Operating Margin: -96.27%
ROA (TTM): -15.00%
ROE (TTM): -27.43%
Revenue (TTM): $97.60M
Revenue/Share (TTM): $3.60
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -58.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 4.28 N/A -10,000.00%
Sep 30, 2025 -0.49 5.53 N/A -10,886.08%
Jun 30, 2025 -0.34 3.21 N/A -11,059.19%
Mar 31, 2025 -0.52 -1.19 N/A 5,630.25%
Dec 31, 2024 -1.11 -0.49 N/A -12,456.00%
Sep 30, 2024 -0.26 -1.22 N/A 7,868.85%
Jun 30, 2024 -0.64 -1.60 N/A 6,000.00%
Mar 31, 2024 -1.00 -1.19 N/A 1,596.64%
Dec 31, 2023 -0.32 -0.99 N/A 6,767.68%
Sep 30, 2023 -0.61 -1.69 N/A 6,390.53%
Jun 30, 2023 -1.98 -0.21 N/A -84,285.71%
Mar 31, 2023 1.87 0.06 N/A 301,666.67%
Dec 31, 2022 4.43 0.98 N/A 35,204.08%
Sep 30, 2022 -1.33 -1.81 N/A 2,651.93%
Jun 30, 2022 -0.82 -1.90 N/A 5,684.21%
Mar 31, 2022 -1.94 -1.44 N/A -3,472.22%
Dec 31, 2021 -1.47 -1.72 N/A 1,453.49%
Sep 30, 2021 -2.05 -1.59 N/A -2,893.08%
Jun 30, 2021 -2.07 -2.15 N/A 372.09%
Mar 31, 2021 -2.15 -1.25 N/A -7,200.00%
Dec 31, 2020 -1.25 -0.88 N/A -4,204.55%
Sep 30, 2020 -0.92 -0.49 N/A -8,775.51%
Jun 30, 2020 -0.55 -0.55 N/A 0.00%
Mar 31, 2020 -0.67 -0.61 N/A -983.61%
Dec 31, 2019 -0.76 -0.53 N/A -4,339.62%
Sep 30, 2019 -0.56 -0.36 N/A -5,555.56%
Jun 30, 2019 -0.07 -0.63 N/A 8,888.89%
Mar 31, 2019 -0.65 -0.58 N/A -1,206.90%
Dec 31, 2018 -0.08 -0.48 N/A 8,333.33%
Sep 30, 2018 -0.42 -0.56 N/A 2,500.00%
Jun 30, 2018 -0.99 -0.70 N/A -4,142.86%
Mar 31, 2018 -1.08 -0.46 N/A -13,478.26%
Dec 31, 2017 -1.08 -0.46 N/A -13,478.26%
Sep 30, 2017 -0.70 -2.66 N/A 7,368.42%
Jun 30, 2017 -0.91 -0.94 N/A 319.15%
Mar 31, 2017 -0.91 -1.26 N/A 2,777.78%
Dec 31, 2016 -1.54 -1.90 N/A 1,894.74%
Sep 30, 2016 -1.96 -1.80 N/A -888.89%
Jun 30, 2016 -1.47 -1.53 N/A 392.16%
Mar 31, 2016 -1.26 -1.51 N/A 1,655.63%
Dec 31, 2015 -1.40 -1.68 N/A 1,666.67%
Sep 30, 2015 -1.40 -2.17 N/A 3,548.39%
Jun 30, 2015 -1.68 -2.01 N/A 1,641.79%
Mar 31, 2015 -1.82 -2.01 N/A 945.27%
Dec 31, 2014 -3.50 -4.20 N/A 1,666.67%
Sep 30, 2014 -5.39 -3.89 N/A -3,856.04%
Jun 30, 2014 -3.99 -3.71 N/A -754.72%
Mar 31, 2014 -3.71 -2.85 N/A -3,017.54%
Dec 31, 2013 -3.15 -2.20 N/A -4,318.18%
Sep 30, 2013 -1.96 -0.63 N/A -21,111.11%
Jun 30, 2013 -0.42 -0.42 N/A 0.00%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $237.03M $N/A $344.07M $103.09M $240.98M
2023-12-31 $292.01M $N/A $429.40M $150.89M $278.51M
2022-12-31 $391.88M $N/A $450.39M $180.08M $270.31M
2021-12-31 $370.49M $N/A $392.81M $164.60M $228.21M
2020-12-31 $462.90M $N/A $476.46M $79.90M $396.55M
2019-12-31 $71.35M $N/A $82.14M $56.35M $25.79M
2018-12-31 $36.71M $N/A $44.20M $30.56M $13.64M
2017-12-31 $24.97M $N/A $52.02M $18.23M $33.79M
2016-12-31 $2.30M $N/A $51.57M $4.34M $47.23M
2015-12-31 $16.66M $N/A $71.68M $2.35M $69.33M
2014-12-31 $2.18M $N/A $22.32M $2.38M $19.94M
2013-12-31 $22.10M $N/A $50.32M $1.64M $48.69M
2012-12-31 $97.00K $N/A $201.00K $768.00K $-567.00K
2011-12-31 $55.00K $N/A $1.20M $219.00K $985.00K

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 15, 2024 N/A N/A N/A N/A N/A N/A
Jun 05, 2024 N/A N/A N/A N/A N/A N/A
Jun 03, 2024 N/A N/A N/A N/A N/A N/A
Mar 25, 2024 N/A N/A N/A N/A N/A N/A
Mar 19, 2024 N/A N/A N/A N/A N/A N/A
Nov 01, 2023 N/A N/A N/A N/A N/A N/A
Oct 02, 2023 N/A N/A N/A N/A N/A N/A
Sep 01, 2023 N/A N/A N/A N/A N/A N/A
Jul 14, 2023 N/A N/A N/A N/A N/A N/A
Jul 14, 2023 N/A N/A N/A N/A N/A N/A
Jul 03, 2023 N/A N/A N/A N/A N/A N/A
May 10, 2023 N/A N/A N/A N/A N/A N/A
May 01, 2023 N/A N/A N/A N/A N/A N/A
Apr 18, 2023 N/A N/A N/A N/A N/A N/A
Apr 03, 2023 N/A N/A N/A N/A N/A N/A
Mar 06, 2023 N/A N/A N/A N/A N/A N/A
Dec 15, 2022 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist